These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 850578)

  • 41. Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus.
    Hicks ML; Piver MS; Puretz JL; Hempling RE; Baker TR; Mcauley M; Walsh DL
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):607-11. PubMed ID: 8330989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometrial cancer: not a benign disease.
    Boronow RC
    Obstet Gynecol; 1976 May; 47(5):630-4. PubMed ID: 772510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extrauterine spread in endometrial carcinoma clinically confined to the uterus.
    Chen SS
    Gynecol Oncol; 1985 May; 21(1):23-31. PubMed ID: 3988126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Para-aortic node biopsy in cervical and endometrial cancers: does it affect survival?
    Blythe JG; Hodel KA; Wahl TP; Baglan RJ; Lee FA; Zivnuska FR
    Am J Obstet Gynecol; 1986 Aug; 155(2):306-14. PubMed ID: 3740147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endometrial cancer: evaluation of spread and follow-up one hundred eighty-nine patients with Stage I or Stage II disease.
    Burrell MO; Franklin EW; Powell JL
    Am J Obstet Gynecol; 1982 Sep; 144(2):181-5. PubMed ID: 7114127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The significance of paraaortic node status in carcinoma of the cervix and endometrium.
    Manetta A; Delgado G; Petrilli E; Hummel S; Barnes W
    Gynecol Oncol; 1986 Mar; 23(3):284-90. PubMed ID: 3957115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracorporeal spread and its prognostic impact in stages I and II (FIGO) endometrial carcinoma.
    Sakuragi N; Tanaka T; Satoh C; Nishiya M; Ohkouchi T; Tsumura N; Takeda N; Hirahatake K; Sagawa T; Ohkubo H
    Asia Oceania J Obstet Gynaecol; 1991 Sep; 17(3):193-201. PubMed ID: 1953428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of irradiation on mixed müllerian tumors of the uterus.
    Perez CA; Askin F; Baglan RJ; Kao MS; Kraus FT; Perez BM; Williams CF; Weiss D
    Cancer; 1979 Apr; 43(4):1274-84. PubMed ID: 221087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A retrospective analysis of 113 operative cases of endometrial carcinoma: prognostic significance of pelvic lymphadenectomy].
    Ikeuchi M; Hoshino T; Shimada I; Michimoto T; Takashima E
    Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1031-8. PubMed ID: 3418213
    [No Abstract]   [Full Text] [Related]  

  • 50. Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes.
    Marchetti DL; Caglar H; Driscoll DL; Hreshchyshyn MM
    Gynecol Oncol; 1990 Apr; 37(1):51-4. PubMed ID: 2323613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paraaortic lymph node biopsy: a twenty-year study.
    Blythe JG; Edwards E; Heimbecker P
    Am J Obstet Gynecol; 1997 Jun; 176(6):1157-62; discussion 1162-5. PubMed ID: 9215168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.
    Creasman WT; Morrow CP; Bundy BN; Homesley HD; Graham JE; Heller PB
    Cancer; 1987 Oct; 60(8 Suppl):2035-41. PubMed ID: 3652025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New treatment procedure for stage I endometrial adenocarcinoma.
    Wolff JP; Pejovic MH; Michel G; Gerbaulet A; Prade M; George M
    Gynecol Oncol; 1986 Jan; 23(1):51-8. PubMed ID: 3943752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometrial carcinoma: treatment of positive paraaortic nodes.
    Feuer GA; Calanog A
    Gynecol Oncol; 1987 May; 27(1):104-9. PubMed ID: 3106173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
    Kadar N; Homesley HD; Malfetano JH
    Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carcinoma IB of the endometrium: spread and prognostic factors.
    Lecca U; Medda F; Parodo G; Puligheddu P; Marcello C
    Eur J Gynaecol Oncol; 1987; 8(2):127-30. PubMed ID: 3569330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determination of the volume of surgical intervention in cancer of the corpus uteri].
    Smakhtina OL; Nugmanova MI; Nigaĭ SV
    Vopr Onkol; 1986; 32(3):86-8. PubMed ID: 3962262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stage II endometrial carcinoma: two modalities of treatment.
    Hernandez W; Nolan JF; Morrow CP; Jernstrom PH
    Trans Pac Coast Obstet Gynecol Soc; 1978; 45():65-9. PubMed ID: 715870
    [No Abstract]   [Full Text] [Related]  

  • 59. Stage II cancer of the endometrium: a pathologic and clinical study.
    Wallin TE; Malkasian GD; Gaffey TA; O'Brien PC; Fountain KS
    Gynecol Oncol; 1984 May; 18(1):1-17. PubMed ID: 6714798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus.
    Chen SS
    Gynecol Oncol; 1989 Feb; 32(2):215-7. PubMed ID: 2910783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.